As the air turns considerably colder, it is natural for extremities such as hands and feet to feel chilly. However, if this ...

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Spinal stenosis is usually a chronic condition, but treatments can help manage symptoms and prevent disability. Learn more.

Positive full results from the Phase III TULIP-SC trial showed the subcutaneous (SC) administration of Saphnelo (anifrolumab) demonstrated a ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Dr. McKinnon: We know that foods associated with systemic inflammation include highly processed foods, things that you get in ...